contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  createdAt
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
    forum {
      threadUrl
    }
    defaultInstrument {
      symbol
      id
    }
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        threadUrl
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        symbol
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


eqt-agrees-to-sale-of-shares-in-beijer-ref-to-melker-schorling-ab

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

EQT is a venture capital firm. The company operates in the investment industry and focuses on private equity and infrastructure investments. The company's portfolio includes companies in sectors such as technology, healthcare and industrials. The business is global with a primary presence in Europe, North America and Asia. EQT was founded in 1994 and is headquartered in Stockholm, Sweden.

EQT has sold its remaining shares in the HVAC and refrigeration wholesaler Beijer Ref for approximately EUR 370 million.   EQT completes final selldown of shares in Beijer Ref, a globally leading wholesaler and distributor of refrigeration, heating, ventilation, and air conditioning (HVAC) technology Under EQT’s ownership, Beijer Ref has more than doubled revenues and tripled EBITDA, supported by accelerated organic growth, disciplined M&A, and continued margin development The sale resulted in aggregate gross proceeds of c. EUR 370 million to the Main Shareholder, of which EQT IX received c. EUR 275 million                     Inderes              EQT exits remaining stake in Beijer Ref - Inderes    EQT completes final selldown of shares in Beijer Ref, a globally leading wholesaler and distributor of refrigeration, heating, ventilation, and air conditioning (HVAC) technology Under EQT'...

EQT is acquiring the German company Exolaunch, which assists satellite companies in getting their satellites into space and into their correct orbits. Exolaunch has already been involved in hundreds of satellite launches - including SpaceX flights. EQT intends to accelerate the company’s international growth, new services, technology, etc. The deal is expected to be completed by the end of this year.   Exolaunch is a global leader in mission management, satellite integration, and deployment technologies for the world’s foremost satellite operators The company has deployed more than 790 satellites across 47 missions and has flown on every SpaceX Transporter and Bandwagon rideshare mission aboard Falcon 9 EQT will support Exolaunch’s next phase of growth through investments in international expansion, product innovation and new service offerings across the space value chain                     Inderes              EQT to acquire Exolaunch, a Germany-based satellite deployment technology and...    Exolaunch is a global leader in mission management, satellite integration, and deployment technologies for the world's foremost satellite operators The company has deployed more than 790 satellites...

Gustav Segerberg will start as EQT’s CFO in July. He succeeds Kim Henriksson, who is transitioning into an advisory role. Segerberg has worked at EQT for a long time and has been involved in, among other things, acquisitions and the company’s growth, etc.   Gustav Segerberg has been appointed Chief Financial Officer of EQT AB, effective as of July 18, 2026. He succeeds Kim Henriksson, who has decided to leave the role after nearly eight years as CFO and transition into a Senior Advisor role. Segerberg has held various senior positions at EQT over the past decade, most recently as Head of the CEO Office, and has been a member of the Executive Committee since 2022. He has played a crucial role in the growth of EQT, including driving EQT AB’s M&A activities and supporting the expansion into the private wealth space. During his tenure, Henriksson has played a central role in EQT’s development into a leading global publicly listed private markets firm. As a Senior Advisor Henriksson will focus on providing strategic support to EQT portfolio companies, including IPO preparations and public company governance.  Gustav Segerberg has been appointed as Chief Financial Officer (“CFO”) of EQT AB and will succeed Kim Henriksson, who has decided to step down following nearly eight years as CFO. The CFO transition is effective as of July 18, 2026. Henriksson will remain with EQT as a Senior Advisor, supporting an orderly transition and continuing to contribute his extensive experience to EQT and its portfolio companies. Segerberg has been instrumental to EQT’s growth, both as a member of the Executive Committee and most recently as Head of the CEO Office. Segerberg has overseen EQT AB’s transformative M&A activities - including the combinations with Baring Private Equity Asia, Exeter Property Group and, most recently, Coller Capital1 - as well as organic growth initiatives like the expansion into private wealth. CEO Per Franzén said: “Having worked closely with Gustav for many years, I have the utmost confidence in his ability. His deep understanding of EQT’s strategy, business model, and stakeholder relationships makes him exceptionally well placed to take on this role. Kim has been a deeply valued partner through one of the most transformative chapters in our firm’s history. I want to extend my sincere gratitude to him for his outstanding contributions to EQT to-date and am pleased that he will continue as a Senior Advisor to the benefit of our portfolio companies, clients and shareholders.” Commenting on his appointment, Segerberg said: “I am honoured to be appointed CFO of EQT and look forward to working with our exceptional team to continue delivering for our shareholders. EQT is a truly unique firm with a strong culture, a clear strategic vision, and substantial opportunities ahead. I am committed to building on the strong financial foundation Kim has established and driving EQT’s continued growth.” Under Henriksson’s leadership, EQT has established a highly professional finance function supporting the firm’s development into a leading global and transparent publicly listed private markets platform. “It has been a privilege to serve as CFO of EQT since 2018 and to have been part of such an extraordinary growth journey. I am proud of what we have achieved together and confident that Gustav will be an outstanding CFO. I look forward to a smooth handover over the coming months and to thereafter work closely with EQT portfolio company boards, management teams and CFOs as a Senior Advisor, including supporting on IPO preparations and public company financial governance”, added Henriksson.                    Inderes              Gustav Segerberg appointed new CFO of EQT AB - Inderes    Gustav Segerberg has been appointed Chief Financial Officer of EQT AB, effective as of July 18, 2026. He succeeds Kim Henriksson, who has decided to leave the role after nearly eight years ...

EQT tavoittelee uudelle kiinteistörahastolleen kuuden miljardin dollarin kokoa.  Rahasto sijoittaa teollisuus- ja logistiikkakiinteistöihin samaan tapaan kuin sen edeltäjä, joka on jo noin “80-prosenttisesti sijoitettu”. EQT Real Estate has set the target size for EQT Exeter Industrial Value Fund VII (or the “Fund”) at USD 6 billion. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size. The Fund’s investment strategy and commercial terms are expected to be materially in line with the predecessor fund, EQT Exeter Industrial Value Fund VI. The predecessor fund, EQT Exeter Industrial Value Fund VI, is as of today approximately 80 percent invested (including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication). Management fees for EQT Exeter Industrial Value Fund VII may be charged on committed capital from the initial closing of the Fund (or a later date designated by EQT in its reasonable discretion). Following the commitment period, management fees on the Fund will be based on net invested capital.                   Inderes              EQT Real Estate sets target fund size for EQT Exeter Industrial Value Fund...    EQT Real Estate has set the target size for EQT Exeter Industrial Value Fund VII (or the "Fund") at USD 6 billion. The actual fund size is dependent on the outcome of the fundraising process...

EQT yrittää kerätä Infrastructure VII -rahastolle 21 miljardia euroa. Rahasto jatkaa pääosin samalla linjalla kuin edeltäjänsä. Uutta rahastoa valmistellaan, koska aiempi rahasto on jo melkeinpä sijoittanut pääomansa.  EQT sets target fund size for EQT Infrastructure VII at EUR 21 billion EQT has today set the target size for the EQT Infrastructure VII fund at EUR 21 billion, corresponding to approximately USD 24.5 billion1. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size; the hard cap of the fund will be set at a later date. The EQT Infrastructure VII fund’s investment strategy is expected to be materially in line with the predecessor fund EQT Infrastructure VI. To ensure continuity between two fund generations, EQT’s capital raisings usually follow a cycle with successor funds targeted to be in a position to commence investment activities when the predecessor fund is close to being fully invested. This means that the commitment period of the predecessor fund typically ends when approximately 80 to 90 percent of its total commitments are invested, with remaining commitments being available primarily for add-on acquisitions and strategic capital injections as well as for ongoing expenses. Management fees for the EQT Infrastructure VII fund may be charged from the earlier of (i) the date of signing of its first investment; or (ii) the date of termination of the commitment period of the EQT Infrastructure VI fund. Management fees on the EQT Infrastructure VI fund will thereafter be based on net invested capital.                   Inderes              EQT sets target fund size for EQT Infrastructure VII at EUR 21 billion - Inderes    THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT ...

EQT is selling a 30 percent minority stake in Nordic Ferry Infrastructure to a certain group, but will remain the company’s majority owner. NFI has grown into a major ferry operations player in the Nordics, transporting over 25 million passengers annually. With the help of the new owners, the company intends to further develop its operations, expand selectively, and invest in low-emission and electric vessels. No figures were mentioned in the release.     A consortium of Rederiaktiebolaget Gotland AB, publ., Interogo Infrastructure and Lægernes Pension to acquire a 30 percent minority stake in Nordic Ferry Infrastructure   Nordic Ferry Infrastructure operates essential ferry infrastructure across the Nordics, serving more than 25 million passengers annually across a network of over 1,400 km   The broadened investor base adds resources to support the next phase of Nordic Ferry Infrastructure’s development, including future fleet decarbonization and electrification investments, selective growth, and further operational development across the platform                      Inderes              EQT broadens investor base in Nordic Ferry Infrastructure following...    A consortium of Rederiaktiebolaget Gotland AB, publ., Interogo Infrastructure and Lægernes Pension to acquire a 30 percent minority stake in Nordic Ferry Infrastructure Nordic Ferry Infrastructure...

Today, EQT released a PRESS release stating that EQT Life Sciences is selling its minority stake in the German biotechnology company Tubulis to Gilead Sciences. The deal could be worth up to $5 billion, with $3.15 billion paid immediately in cash. Tubulis develops new cancer drugs, and EQT helped it grow and develop. Going forward, Tubulis will operate as part of Gilead and continue its research internationally.  Press Release EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion  Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company EQT Life Sciences led the Series B2 financing of Tubulis in March 2024, and has since supported the Company at board level in its growth to a leading global clinical-stage ADC company  EQT Life Sciences is pleased to announce that the LSP 7 fund (“EQT Life Sciences”) has exited its minority stake in Tubulis (the “Company”), a Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), through a sale to Gilead Sciences [Nasdaq: GILD].  Tubulis’ lead asset, TUB-040, a NaPi2b-directed topoisomerase-I inhibitor (TOPO1i) ADC, is currently in Phase 1b/2 development for platinum-resistant ovarian cancer and non-small cell lung cancer (NSCLC). Gilead will also acquire TUB-030, a 5T4 targeted ADC, which has demonstrated promising initial clinical data across various solid tumor types as well as a next-generation ADC platform and a promising early pipeline. EQT Life Sciences co-led the oversubscribed Series B2 financing in 2024, and since then, has helped Tubulis advance into a clinical-stage oncology player, progress its pipeline, and build a differentiated antibody-drug conjugate platform targeting solid tumors. Working closely with the management team, EQT Life Sciences supported this journey through active board involvement and strategic guidance, helping position Tubulis as a partner of choice in a rapidly growing and highly competitive field. The transaction represents a strong and strategic outcome for LSP 7 and its co-investors, and reflects EQT Life Sciences’ ambition to back outstanding science early, helping companies scale through critical inflection points into globally relevant businesses. Today’s announcement also underscores the continued demand for innovative oncology platforms that can address significant unmet medical needs. “From the outset, we believed our conjugation technology platforms could have broad impact across the ADC field, and the initial data from TUB-040 have reinforced that conviction,” said Dominik Schumacher, PhD, Chief Executive Officer and Co-founder of Tubulis. “Joining Gilead allows us to build on this foundation within an organization that brings deep scientific expertise, global development capabilities, and the scale needed to translate innovation into medicines for patients worldwide. Through our existing collaboration, Gilead has already seen the potential of our technologies and together, we are well positioned to accelerate the development of our ADC pipeline. I’m deeply grateful to the Tubulis team, our Board of Directors, investors, and partners for their commitment and helping make this milestone possible.” “From day one, it was clear that Tubulis had both the science and the ambition to compete at the very highest level in oncology,” said Christoph Broja, Partner at EQT Life Sciences and Board Director at Tubulis." A European-born platform with world-class talent and technology, this is exactly the kind of company EQT Life Sciences was built to back. Today’s announcement is a testament to that conviction, and we are proud to have supported its journey from Munich to the global stage" Following the close of the transaction, Tubulis will operate as a dedicated ADC research organization within Gilead, with the Munich site serving as a hub for ADC innovation, building on its integrated discovery, manufacturing, and clinical capabilities to advance next generation ADCs. Terms of the Transaction Under the terms of the sale and purchase agreement, Gilead will acquire all of the outstanding equity of Tubulis for $3.15 billion in upfront cash consideration on a cash-free, debt-free basis, subject to customary adjustments, which is payable at closing, and up to $1.85 billion in contingent milestone payments. Closing of the transaction is subject to expiration or termination of certain regulatory filings and other customary conditions. The transaction is expected to close in the second quarter of 2026. Gilead plans to finance the transaction with a combination of cash on hand and senior unsecured notes. Centerview Partners LLC and Allen & Company LLC are acting as financial advisors for Gilead. J.P. Morgan Securities LLC is acting as the exclusive financial advisor for Tubulis. Covington & Burling LLP, Arnold & Porter LLP, and Venable LLP are serving as legal counsel to Gilead. Goodwin Procter LLP and CMS Hasche Sigle are serving as legal counsel to Tubulis.                    Inderes              EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead...    Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company EQT Life Sciences led the Series B2 financing of Tubulis...

Breeze TopCo S.à r.l, an affiliate of the EQT IX fund ("EQT") has signed an agreement to sell its entire holding of non-listed A-shares in Beijer Ref to Melker Schörling AB ("Melker Schörling...

<div class="abstract"><p>Breeze TopCo S.à r.l, an affiliate of the EQT IX fund ("EQT") has signed an agreement to sell its entire holding of non-listed A-shares in Beijer Ref to Melker Schörling AB ("Melker Schörling") at an undisclosed premium.&nbsp;</p></div><p><span>As part of the transaction, Peter Jessen Jürgensen, via Labotek International A/S and KLS Jessen AB, agrees to sell his entire holding of A-shares to EQT, in exchange for 4,146,592 B-shares from EQT. The A-shares received by EQT from Peter Jessen Jürgensen will, upon completion of that transfer, be included in EQT's sale of its entire holding of A-shares to Melker Schörling.</span></p><p><span>The closing of the transactions are subject to customary regulatory approvals. Following completion of the transactions, EQT will hold 30,742,835 B-shares in Beijer Ref.</span></p><p><span><strong>Contact</strong><br>EQT Press Office, press@eqtpartners.com</span></p><div></div>

EQT agrees to sale of shares in Beijer Ref to Melker Schörling AB

EQT agrees to sale of shares in Beijer Ref to Melker Schörling AB